Novo Nordisk grant to Pia Rantakari and Klaus Elenius
The Novo Nordisk Foundation awarded 2024 grants to five researchers from the University of Turku, totaling approximately €2,204,294.
Among the grant recipients were:
Docent, InFLAMES and Turku Bioscience group leader Pia Rantakari. Her research titled Unveiling the Role of Pituitary Gland Macrophages in Polycystic Ovarian Syndrome: Towards Novel Therapeutics got DKK 2.997.685 (approx. 401 988 €) funding.
Professor, BioCity Turku Director, Turku Bioscience group leader Klaus Elenius. His research titled Overcoming Cancer drUg Resistance by targeting ERBB3 (CURE) got DKK 5.981.741 (approx. 802 149 €) funding.
Warm congratulations!
Recent Posts
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026
- Rector Widen Visited Our Centre Åbo Akademi University Rector, Gunilla Widén, visited our Centre on Wednesday, February 25th, to learn Read moreFebruary 27, 2026
- Laura Elo is awarded the Leif C. Groop Award for outstanding research on type 1 diabetesLaura Elo a group leader at Turku Bioscience is awarded the Leif C. Groop Award Read moreFebruary 23, 2026
- Finnish Cultural Foundation Awards Funding to Turku Bioscience ResearchersWe are pleased to announce recent funding from The Finnish Cultural Foundation: Congratulations to all Read moreFebruary 16, 2026
- Newly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetesAn international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important Read moreJanuary 20, 2026
- Turku Bioscience Centre Is Recruiting New Research LeadersTurku Bioscience Centre is currently inviting applications for two key research positions that will strengthen Read moreJanuary 13, 2026